GranBio® Technologies converts biorefinery research facility in Georgia to hand sanitizer production

In Georgia, GranBio Technologies, via its wholly-owned subsidiary AVAPCO LLC, (Atlanta, Georgia), has converted its biorefinery research facility in Thomaston, Georgia to the production of hand sanitizer to assist organizations and consumers that are experiencing difficulties obtaining hand sanitizer products during the Nationwide COVID-19 Public Health Emergency. Targeted customers include nursing homes, small businesses, hospitals, police and fire departments, universities, and individual consumers. The product is sold in one gallon bottles and 50-gallon drums at http://www.GAsanitizer.com or by contacting [email protected] for bulk or tax exempt orders.

AVAPCO is registered with the U.S. Food and Drug Administration (FDA) as an over-the-counter (OTC) drug manufacturer to prepare alcohol-based hand sanitizers pursuant to FDA’s Temporary Policy for Preparation of Certain Alcohol-Based Hand Sanitizer Products During the COVID-19 Public Health Emergency declared by the Secretary of Health and Human Services.